David Berntsen to Disease Progression
This is a "connection" page, showing publications David Berntsen has written about Disease Progression.
Connection Strength
1.865
-
Axial Growth and Myopia Progression After Discontinuing Soft Multifocal Contact Lens Wear. JAMA Ophthalmol. 2025 Feb 01; 143(2):155-162.
Score: 0.935
-
Atropine, 0.01%, for Myopia Control. JAMA Ophthalmol. 2023 08 01; 141(8):766-767.
Score: 0.210
-
Delaying the Onset of Nearsightedness. JAMA. 2023 02 14; 329(6):465-466.
Score: 0.204
-
Peripheral defocus and myopia progression in myopic children randomly assigned to wear single vision and progressive addition lenses. Invest Ophthalmol Vis Sci. 2013 Aug 27; 54(8):5761-70.
Score: 0.106
-
A randomized trial using progressive addition lenses to evaluate theories of myopia progression in children with a high lag of accommodation. Invest Ophthalmol Vis Sci. 2012 Feb; 53(2):640-9.
Score: 0.095
-
Accommodative lag and juvenile-onset myopia progression in children wearing refractive correction. Vision Res. 2011 May 11; 51(9):1039-46.
Score: 0.089
-
IMI 2023 Digest. Invest Ophthalmol Vis Sci. 2023 05 01; 64(6):7.
Score: 0.052
-
Trends in myopia management attitudes and strategies in clinical practice: Survey of eye care practitioners in Africa. Cont Lens Anterior Eye. 2023 02; 46(1):101597.
Score: 0.048
-
IMI 2021 Yearly Digest. Invest Ophthalmol Vis Sci. 2021 04 28; 62(5):7.
Score: 0.045
-
Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial. JAMA. 2020 08 11; 324(6):571-580.
Score: 0.043
-
IMI - Clinical Myopia Control Trials and Instrumentation Report. Invest Ophthalmol Vis Sci. 2019 02 28; 60(3):M132-M160.
Score: 0.039